Rockville, MD, March 06, 2025 (GLOBE NEWSWIRE) — According to Fact.MR, a market research and competitive intelligence provider, the global amniocentesis needle market is estimated to reach a valuation of USD 175.0 million in 2025 and is expected to grow at a CAGR of 3.2 % during the forecast period of 2025 to 2035.
Amniocentesis is an important medical procedure through which prenatal diagnosis is done. The process in which the amniotic fluid surrounds the fetus is removed for the sake of establishing if there exists the presence of any genetic disorders or not and even their health status. The procedure of amniocentesis is done using an amniocentesis needle.
Growth in accessibility and adoption of prenatal tests is believed to aid in the growth of the amniocentesis needle market as a whole. Some of the major driving forces that would influence the sales of amniocentesis needles increasing recommendations by doctors, greater success rate of amniocentesis, greater awareness about congenital disorders, better knowledge about Down’s syndrome, an increased population of pregnant women, and increase funding in health-related research and development.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=362
Key Takeaways from Market Study
- The global amniocentesis needle market is projected to grow at 2% CAGR and reach USD 239.8 million by 2035
- The market created an absolute $ opportunity of USD 64.8 million growing at a CAGR of 2 % between 2025 to 2035
- North America is a prominent region that is estimated to hold a market share of 5% in 2035
- The type of needles which ranges between 100 mm to 150 mm are estimated to grow at a CAGR OF 3.8% creating an absolute opportunity of USD 34.7 Million between 2025 and 2035.
- North America and East Asia are expected to create an absolute $ opportunity of USD 33.6 million collectively
“Carrying out prenatal test by using amniocentesis needle for detection of genetic disorders” says a Fact.MR analyst.
Leading Players Driving Innovation in the Amniocentesis Needle Market:
Key players in the amniocentesis needle market are Smiths Medical, Becton Dickinson and Company, Biopsybell Srl, Integra LifeSciences Holdings Corporation, Laboratoire Ccd, Rocket Medical PLC, Medline Industries Inc., Medtronic PLC, RI.MOS. Srl, Cook Medical LLC, CooperSurgical Inc., Tsunami Medical and other prominent players.
Market Development
The amniocentesis needle market globally is very competitive at the local level, and this will have a direct impact on the sales of major companies in the amniocentesis needle marketplace. Major and minor market players will focus on product innovation to enhance their sales potential and will look for organic as well as inorganic growth strategies.
- In September 2023, Medtronic introduced a next-generation amniocentesis needle with enhanced safety features, including a thinner gauge and improved echogenicity for better ultrasound visibility. The new design aims to reduce patient discomfort and procedural risks, catering to the growing demand for safer prenatal diagnostic tools.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=362
Amniocentesis Needle Industry News:
- CooperSurgical teamed up with a top supplier of ultrasound technology in August 2024 to incorporate cutting-edge imaging features into their amniocentesis needles. By reducing problems and increasing procedural accuracy, our partnership seeks to increase the overall effectiveness of prenatal diagnostics.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global amniocentesis needle market, presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.
The study reveals essential insights on the basis of the Type (100 to 150mm, larger than 150mm, smaller than 100mm), Procedure (amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, cordocentesis), End-Users (hospitals, diagnostic centres, clinics and others) across major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and Middle East & Africa).
Check out More Related Studies Published by Fact.MR:
Cardiac Prosthetic Devices Market: Sales are predicted to increase at a CAGR of 7.6% from 2022 to 2027. In 2022, the global cardiac prosthetic devices market is valued at US$ 6.6 billion and is projected to reach a market size of US$ 9.5 billion by 2027.
Computer Aided Detection Market: Size is forecasted to surge ahead at a CAGR of 10% from 2023 to 2033. The market is valued at US$ 1.5 billion in 2023 and is thus anticipated to reach US$ 3.9 billion by 2033-end.
Wireless Portable Medical Devices Market: Size was valued at US$ 15 Bn in 2020, and is projected to top US$ 33 Bn by 2031, expanding at a CAGR of 11%.
Chemiluminescence Immunoassay (CLIA) Analyzers Market: Analysers is projected to grow at a compound annual growth rate (CAGR) of 6.5%, from a 2023 valuation of US$6.4 billion to US$12 billion by the end of 2033.
Insulin Delivery Devices Market: Size have reached at US$ 16.8 Billion in 2023, and is expected to secure a valuation of US$ 33.1 Billion by 2033-end, with a growing compound annual growth rate (CAGR) of 7% during the forecast period from 2023 to 2033.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
